Skip to main content
Caplight Logo









Provenance Bio

Provenance Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://provenance.bio/

Last Round

Grant

Sep 22, 2021

Total Funding Raised

$288,000

Company Overview

Provenance Bio is a biotechnology company that develops synthetic biology tools to produce animal-free proteins, including collagen and gelatin, for applications in food, pharmaceuticals, and biomaterials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Sustainable Materials, Fashion & Beauty, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

synthetic biologyprecision fermentationrecombinant proteinanimal-free collagenanimal-free gelatinlab-grown proteincellular agricultureprotein expression platformbiomaterialstissue engineeringcultivated meatcollagen peptidesalternative proteinsustainable ingredientsB2B biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Provenance Bio Comparables

Compare Provenance Bio with similar companies based on industry and business-model similarity.

Provenance Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jellatech
88%
VeCollal
85%
Geltor
83%

Provenance Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 22, 2021
AcceleratorMar 19, 2018
AcceleratorMar 19, 2018

Key People

Founding team and executive leadership

Michalyn Andrews

CEO Co-founder, CEO

Founding Team

Provenance Bio Investors

Notable investors and investment history

Provenance Bio investors
InvestorRounds
Plug and Play Tech CenterAccelerator
Fashion for GoodAccelerator
National Institute of General Medical SciencesGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 74% MoM, reaching 1.7K.

  • Jan 1, 2026

    Monthly visitors increased 59% MoM, reaching 1.5K.

Provenance Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Provenance Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Provenance Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2020
Last FundingSep 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?